Wearable cues help walking timing
- Trial ID
- NCT06430151
- Official Title
- Useability and Acceptability of the CUE1 Device in Older People With Parkinson's Disease
- Goal
- Wearable cues help walking timing
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Dr Alistair Mackett
- Study Type
- INTERVENTIONAL
- Enrollment
- 20 participants
- Conditions
- Parkinson Disease
- Interventions
- CUE1
Plain-Language Summary
The goal is to find out whether older people with Parkinson's can comfortably use and accept the CUE1 wearable as a help for walking and movement timing. CUE1 is a small, chest-worn adhesive device that delivers gentle tactile cues to help time steps and posture; it is a non-drug, wearable aid so it would be used alongside levodopa rather than interacting with it. The focus is on real-world usability, comfort, and whether people are happy to wear it, not on testing a new medication. They are looking for 20 people aged 60 to 100 with a confirmed Parkinson's diagnosis under the Cambridge movement disorder service, excluding those with dementia or other major neurological diseases, atypical parkinsonism, implanted devices like pacemakers or DBS, chest trauma or adhesive sensitivity, severe mobility-limiting conditions, inability to consent, or current participation in another intervention trial.
Locations
- Cambridge University Hospitals Foundation Trust, Cambridge, United Kingdom
Frequently Asked Questions
- What is this trial testing?
- This trial is studying CUE1. The goal is to find out whether older people with Parkinson's can comfortably use and accept the CUE1 wearable as a help for walking and movement timing. CUE1 is a small, chest-worn adhesive device that delivers gentle tactile cues to help time steps and posture; it is a non-drug, wearable aid so it would be used alongside levodopa rather than interacting with it. The focus is on real-world usability, comfort, and whether people are happy to wear it, not on testing a new medication. They are looking for 20 people aged 60 to 100 with a confirmed Parkinson's diagnosis under the Cambridge movement disorder service, excluding those with dementia or other major neurological diseases, atypical parkinsonism, implanted devices like pacemakers or DBS, chest trauma or adhesive sensitivity, severe mobility-limiting conditions, inability to consent, or current participation in another intervention trial.
- Who can participate?
- Participants must be between 60 Years and 100 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 6 months.